Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry

類似資料

• From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid
  著者:: Hirtz, Christophe, 等
  出版事項: (2016)
• Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
  著者:: Barthélemy, Nicolas R., 等
  出版事項: (2020)
• Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches
  著者:: Vialaret, Jerome, 等
  出版事項: (2018)
• CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease
  著者:: Horie, Kanta, 等
  出版事項: (2020)
• Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
  著者:: Lehmann, Sylvain, 等
  出版事項: (2020)